Exon-skipping drugs present a critical test for the FDA’s goal of encouraging treatments for rare disease.

Longevity clinics promise personalized health advice and cutting-edge tests. Now major hospitals are entering the business, at costs reaching $45,000 a year.

Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.

Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.

Addiction clinics are seeing a surge in patients dependent on potent kratom and 7-OH products.

The influential panel hasn't met in more than a year, after Kennedy canceled its meeting.

Naloxone and harm reduction measures may be helping to curb drug overdose deaths, a new report says.

A CMS rule finalized this week may prove more difficult to challenge than previous Trump administration actions to end transgender care for young people.

Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.

The U.S. can save lives from excess alcohol use without taking drastic measures. Here are 12 steps that can help.

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.

Attorney General Ken Paxton said on Friday that Texas Children’s must also pay $10 million to the state because it illegally provided transgender care to kids.

More than 1 in 8 pregnant women report drinking. Doctors warn fetal alcohol disorders may be more common than many realize, perhaps more common than autism.

In response to an Ebola outbreak, the U.S. has banned entry for foreign travelers who have been in the Democratic Republic of the Congo, Uganda, or South Sudan in the past 21 days.

Americans exposed to Ebola outbreak, Bill Cassidy's primary defeat, and more health news from Morning Rounds

“The fundamental question is: Who gets to regulate mifepristone?”

The thinking about what risk Covid poses — or doesn't pose — has shifted in recent years. What does it mean for you?

Suicide rates among young people dropped 11% after the U.S. launched the 988 national suicide and crisis hotline, a new study shows

State restrictions, Trump administration policies, and waning public support are further limiting adults' access to transgender care

How a report led by a right-wing pundit laid the groundwork for upending gender-affirming treatment

A mother's persistence helps revive an all-but-abandoned drug class and could aid her son and thousands of others with neuromuscular conditions.

A Supreme Court ruling this week on gender and sexuality “conversion therapy” could narrow the authority of state medical boards over care involving speech

Inside the movement to resurrect conversion therapy.

The Supreme Court will hear arguments Tuesday in a challenge to a Colorado law banning mental health practitioners from performing conversion therapy

The Trump administration claims there's widespread fraud in home-based care, but officials haven't offered any evidence.

The leading medical school accreditation body in the U.S. has removed language from its standards requiring schools to teach about health inequities

A U.S. district judge said he will vacate a declaration by Kennedy that asserted gender-affirming care for young trans people does not meet medical standards of care.

Many vaccines confer surprising knock-on, or indirect, health benefits when they have been put into widespread use.

Breaking: A federal judge on Monday stalled major parts of health secretary Robert F. Kennedy Jr.’s campaign to remake vaccine policy in the U.S.

A federal appeals court will hear arguments Friday in the Trump administration's effort to subpoena patient records on gender-affirming care

Stanley Plotkin, the 93-year-old "godfather of vaccines," is watching his field’s achievements slip away.

Exclusive: Harvard geneticist George Church knew more about Jeffrey Epstein's activities than he has previously said, before accepting new donations from the sex offender.

The statements largely echo existing practices, but come as political pressure on transgender care grows.

Lobbyists told STAT they believe the odds of approval go up if a decision can be spun as a win for the Trump administration.

Chest binders are a common first step to explore gender identity. Restricting them could push people back to unsafe DIY methods.